Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of amino acid composition to medicine for treating fetal nervous system development diseases

A nervous system development and amino acid technology, which is applied in the application field of amino acid composition in the drug for fetal nervous system development disease, can solve the problems of increased risk of fetal aneuploidy, and achieves the solution of simple lateral ventricle dilatation and normal and smooth development. , the effect of normal energy metabolism

Pending Publication Date: 2021-11-09
泉州医学高等专科学校
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Ultrasonographic soft marker abnormalities are ultrasound-detectable morphological variations whose etiology remains unknown, are usually transient and nonpathologic, but suggest an underlying increased risk of fetal aneuploidy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of amino acid composition to medicine for treating fetal nervous system development diseases
  • Application of amino acid composition to medicine for treating fetal nervous system development diseases
  • Application of amino acid composition to medicine for treating fetal nervous system development diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0051] The specific implementation manners of the present invention will be further described below with reference to the accompanying drawings.

[0052] Such as Figure 1 to Figure 15 Shown, the pharmaceutical use of the amino acid composition, the amino acid composition is used for the preparation of pharmaceutical compositions for the prevention and treatment of fetal nervous system developmental diseases.

[0053] Furthermore, the developmental diseases of the fetal nervous system include: simple choroid plexus cyst and simple dilatation of the lateral ventricles.

[0054] Furthermore, the amino acid composition includes: amino acids and vitamins, the amino acids include aspartic acid, lysine, ornithine, citrulline and β-aminoisobutyric acid; the vitamins include B 3 , B 5 , B 6 , B 9 and B 12 .

[0055] Further, the amino acid metabolism characteristics of the simple choroid plexus cyst and simple lateral ventricle dilation are derived from the amino acid metabolism c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of an amino acid composition to a medicine for treating fetal nervous system development diseases, including a pharmaceutical application of the amino acid composition. The amino acid composition is used for preparing the medicine composition for preventing and treating the fetal nervous system development diseases. The invention further discloses an amino acid composition identification and statistical processing method. Amino acid metabolism characteristics of fetal amniotic fluid with abnormal central nervous system isolated soft indexes obtained by ultrasonic guided amniotic cavity puncture are studied to obtain the pharmaceutical composition for preventing and treating fetal nervous system development diseases, so that the diseases of simple ventricular plexus cyst and simple lateral ventricular dilatation of a fetus are treated, and the development and perfection of a fetal cranial nervous system are promoted.

Description

technical field [0001] The present invention relates to the technical field of medicine, more specifically to the application of an amino acid composition in medicine for developing diseases of the fetal nervous system. Background technique [0002] Ultrasonographic soft marker abnormalities refer to ultrasound-detectable morphological variations whose etiology remains unknown, are usually transient and nonpathologic, but suggest an underlying increased risk of fetal aneuploidy. Amniotic fluid comes from the mother, fetus and placental tissue, and it is in direct contact with multiple organs of the fetus. It can reflect the health status of the mother and the fetus at the same time, including fetal structural abnormalities, chromosomal abnormalities, and maternal diseases. [0003] The development of the fetal central nervous system is closely related to amino acids, among which excitatory amino acids play a variety of physiological and pathophysiological roles in the centra...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4415A61K31/519A61K31/714A61K31/198A61K31/455A61K31/197A61P3/02A61P25/00G16H50/20
CPCA61K31/198A61K31/455A61K31/197A61K31/4415A61K31/519A61K31/714A61P3/02A61P25/00G16H50/20A61K2300/00
Inventor 吕国荣
Owner 泉州医学高等专科学校
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products